Trial reportWorld journal of gastrointestinal surgery2025
Modified Pingwei Baohe decoction improves postoperative recovery in gastric cancer patients.
Trial report in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Traditional Chinese Medicine in Gastric Cancer: A Narrative Review of Mechanisms, Clinical Evidence, Technical Advances, and Translational Challenges.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric cancer is a major global health issue, especially in East Asia. Radical gastrectomy, the primary treatment, often leads to complications like malnutrition and infection, impairing recovery. Traditional Chinese medicine may offer benefits in regulating gastrointestinal function and immunity. This study investigated the effects of a modified Pingwei Baohe decoction (MPBD) on postoperative immune function and nutritional status in gastric cancer patients.
aimTo explore the influence of MPBD on the postoperative immune function and nutritional status of patients with gastric cancer.
methodsA total of 55 gastric cancer patients who underwent radical proximal gastrectomy in Hebei Provincial People's Hospital and The Fourth Hospital of Hebei Medical University from June 2023 to June 2025 were selected as the research objects and divided into the observation group (28 cases, receiving chemotherapy plus MPBD) and the control group (27 cases, receiving chemotherapy alone) at a ratio of 1:1 according to the random number table method. Inflammatory indicators, immune function, nutritional status, and gastrointestinal function recovery time were compared before and 28 days after intervention.
resultsAfter 28 days, the observation group showed significantly lower levels of inflammatory markers (IL-6, IL-4, IL-2, IL-17A, IFN-γ, TNF-α, IL-10), neutrophil-to-lymphocyte ratio (NLR), and proportion of CONUT score > 2, alongside significantly higher levels of CD3
conclusionMPBD significantly enhances postoperative immune function, mitigates inflammatory responses, improves nutritional status, and accelerates gastrointestinal function recovery in gastric cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.